Cargando…
Awareness and attitudes of oncology specialists toward dihydropyrimidine dehydrogenase testing in Saudi Arabia
BACKGROUND: Fluoropyrimidines (FP) are among the most common class of prescribed anti‐neoplastic drugs. This class has severe to moderate toxicity in around 10%–40% of those who take 5‐fluorouracil (5‐FU) or capecitabine for the treatment of cancer. In practice many patients with severe toxicities f...
Autores principales: | Sukkarieh, Hatouf H., AlSagoor, Turki, Alnuhait, Mohammed, Bustami, Rami, Bryson, Scott, Adem, Fatima Mohammed Kebir, Abdalla, Hana, Karbani, Gulsan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939998/ https://www.ncbi.nlm.nih.gov/pubmed/36806724 http://dx.doi.org/10.1002/cnr2.1704 |
Ejemplares similares
-
A highlight on carbamazepine-induced adverse drug reactions in Saudi Arabia: a retrospective medical records-based study
por: Sukkarieh, Hatouf H., et al.
Publicado: (2023) -
The current practice of using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in diabetic hypertensive and non-hypertensive patients: Is there a room for vitamin D?
por: Sukkarieh, Hatouf H., et al.
Publicado: (2020) -
Current umbilical cord clamping practices and attitudes of obstetricians and midwives toward delayed cord clamping in Saudi Arabia
por: Ibrahim, Nadia O., et al.
Publicado: (2017) -
Dihydropyrimidine Dehydrogenase Deficiency: To Screen or Not to Screen?
por: Vogel, Wendy H., et al.
Publicado: (2020) -
Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity
por: Milano, G, et al.
Publicado: (1999)